Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

H7 Hemagglutinin nanoparticles retain immunogenicity after >3 months of 25°C storage.

Chang TZ, Deng L, Wang BZ, Champion JA.

PLoS One. 2018 Aug 9;13(8):e0202300. doi: 10.1371/journal.pone.0202300. eCollection 2018.

2.

Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures.

Geeraedts F, Saluja V, ter Veer W, Amorij JP, Frijlink HW, Wilschut J, Hinrichs WL, Huckriede A.

AAPS J. 2010 Jun;12(2):215-22. doi: 10.1208/s12248-010-9179-z. Epub 2010 Mar 2.

3.

N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.

Amidi M, Romeijn SG, Verhoef JC, Junginger HE, Bungener L, Huckriede A, Crommelin DJ, Jiskoot W.

Vaccine. 2007 Jan 2;25(1):144-53. Epub 2006 Aug 4.

PMID:
16973248
4.

Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.

Pillet S, Racine T, Nfon C, Di Lenardo TZ, Babiuk S, Ward BJ, Kobinger GP, Landry N.

Vaccine. 2015 Nov 17;33(46):6282-9. doi: 10.1016/j.vaccine.2015.09.065. Epub 2015 Oct 2.

PMID:
26432915
5.

Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine.

Sawaengsak C, Mori Y, Yamanishi K, Mitrevej A, Sinchaipanid N.

AAPS PharmSciTech. 2014 Apr;15(2):317-25. doi: 10.1208/s12249-013-0058-7. Epub 2013 Dec 17.

6.

Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus.

Pushko P, Pujanauski LM, Sun X, Pearce M, Hidajat R, Kort T, Schwartzman LM, Tretyakova I, Chunqing L, Taubenberger JK, Tumpey TM.

Vaccine. 2015 Sep 11;33(38):4975-82. doi: 10.1016/j.vaccine.2015.07.026. Epub 2015 Jul 21.

7.

Stabilization of HAC1 influenza vaccine by spray drying: formulation development and process scale-up.

Zhu C, Shoji Y, McCray S, Burke M, Hartman CE, Chichester JA, Breit J, Yusibov V, Chen D, Lal M.

Pharm Res. 2014 Nov;31(11):3006-18. doi: 10.1007/s11095-014-1394-3. Epub 2014 May 24.

PMID:
24858396
8.

A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge.

Shoji Y, Jones RM, Mett V, Chichester JA, Musiychuk K, Sun X, Tumpey TM, Green BJ, Shamloul M, Norikane J, Bi H, Hartman CE, Bottone C, Stewart M, Streatfield SJ, Yusibov V.

Hum Vaccin Immunother. 2013 Mar;9(3):553-60. Epub 2013 Jan 7.

9.

Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.

Gupta NK, Tomar P, Sharma V, Dixit VK.

Vaccine. 2011 Nov 8;29(48):9026-37. doi: 10.1016/j.vaccine.2011.09.033. Epub 2011 Sep 20.

PMID:
21939718
10.

Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection.

To KK, Zhang AJ, Chan AS, Li C, Cai JP, Lau CC, Li CG, Jahan AS, Wu WL, Li L, Tsang AK, Chan KH, Chen H, Yuen KY.

Arch Virol. 2015 Mar;160(3):777-86. doi: 10.1007/s00705-014-2314-x. Epub 2015 Jan 24.

PMID:
25616843
11.

Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.

Venereo-Sanchez A, Gilbert R, Simoneau M, Caron A, Chahal P, Chen W, Ansorge S, Li X, Henry O, Kamen A.

Vaccine. 2016 Jun 17;34(29):3371-80. doi: 10.1016/j.vaccine.2016.04.089. Epub 2016 May 5.

PMID:
27155499
12.

Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge.

Mallajosyula JK, Hiatt E, Hume S, Johnson A, Jeevan T, Chikwamba R, Pogue GP, Bratcher B, Haydon H, Webby RJ, McCormick AA.

Hum Vaccin Immunother. 2014;10(3):586-95. Epub 2013 Dec 30.

13.

Recombinant influenza H7 hemagglutinin containing CFLLC minidomain in the transmembrane domain showed enhanced cross-protection in mice.

Wang Y, Zhang Y, Wu J, Lin Y, Wu Z, Wei Y, Wei X, Qin J, Xue C, Liu GD, Cao Y.

Virus Res. 2017 Oct 15;242:16-23. doi: 10.1016/j.virusres.2017.09.008. Epub 2017 Sep 12.

PMID:
28912070
14.

Nanodiamond enhances immune responses in mice against recombinant HA/H7N9 protein.

Pham NB, Ho TT, Nguyen GT, Le TT, Le NT, Chang HC, Pham MD, Conrad U, Chu HH.

J Nanobiotechnology. 2017 Oct 5;15(1):69. doi: 10.1186/s12951-017-0305-2.

15.

Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins.

Blanchfield K, Kamal RP, Tzeng WP, Music N, Wilson JR, Stevens J, Lipatov AS, Katz JM, York IA.

Influenza Other Respir Viruses. 2014 Nov;8(6):628-35. doi: 10.1111/irv.12285. Epub 2014 Sep 12.

16.

An evaluation of the cold chain technology in South-East, Nigeria using Immunogenicity study on the measles vaccines.

Oli AN, Agu RU, Ihekwereme CP, Esimone CO.

Pan Afr Med J. 2017 Jun 23;27(Suppl 3):28. doi: 10.11604/pamj.supp.2017.27.3.11491. eCollection 2017.

17.

VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.

Kuck LR, Byrne-Nash R, Gillis J, Bueter K, Couzens LK, Eichelberger MC, Rowlen KL.

Vaccine. 2018 May 17;36(21):2937-2945. doi: 10.1016/j.vaccine.2018.04.048. Epub 2018 Apr 23.

18.

Immunization with a low dose of hemagglutinin-encoding plasmid protects against 2009 H1N1 pandemic influenza virus in mice.

Fang J, Chen Z, Liu X, Li H, Wang J, Shen X, Chen W, Liu Y, Wang Y, Zhao P, Qi Z.

J Virol Methods. 2011 May;173(2):314-9. doi: 10.1016/j.jviromet.2011.03.001. Epub 2011 Mar 12.

PMID:
21392537
19.

Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model.

Jacobsen H, Rajendran M, Choi A, Sjursen H, Brokstad KA, Cox RJ, Palese P, Krammer F, Nachbagauer R.

MBio. 2017 Sep 19;8(5). pii: e01463-17. doi: 10.1128/mBio.01463-17.

20.

Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.

Moon HJ, Lee JS, Talactac MR, Chowdhury MY, Kim JH, Park ME, Choi YK, Sung MH, Kim CJ.

Vet Microbiol. 2012 Dec 7;160(3-4):277-89. doi: 10.1016/j.vetmic.2012.05.035. Epub 2012 Jun 7.

PMID:
22763171

Supplemental Content

Support Center